Related Experiment Video
Updated: May 29, 2026

Anatomical Reconstructions of the Human Cardiac Venous System using Contrast-computed Tomography of Perfusion-fixed Specimens
Published on: April 18, 2013
Prevention of contrast-induced nephropathy with haemofiltration in high-risk patients after percutaneous coronary
J R Rey1, D Iglesias, E López De Sá
1La Paz University Hospital, Cardiology, Madrid, Spain. jreyblas@hotmail.com
Insights
Prophylactic haemofiltration (PHF) significantly reduced contrast-induced nephropathy (CIN) in high-risk patients undergoing percutaneous coronary intervention (PCI). This intervention shows promise in preventing kidney damage after PCI procedures.
Area of Science:
- Cardiology
- Nephrology
- Interventional Cardiology
Background:
- Contrast-induced nephropathy (CIN) incidence is rising post-percutaneous coronary intervention (PCI).
- High-risk patients undergoing PCI are particularly susceptible to CIN.
- Identifying effective preventative strategies for CIN is crucial.
Purpose of the Study:
- To evaluate the efficacy of prophylactic haemofiltration (PHF) in preventing CIN.
- To assess the benefits of PHF in high-risk patients undergoing PCI.
- To compare CIN incidence between patients receiving PHF and controls.
Main Methods:
- Retrospective analysis of 20 patients who underwent PHF post-PCI for acute coronary syndrome.
- Comparison with 20 matched control patients with similar risk factors.
- Analysis of CIN incidence, acute kidney failure, heart failure, and mortality.
Main Results:
- The PHF group showed a significantly lower incidence of CIN (30%) compared to the control group (65%, P=0.03).
- Baseline characteristics, including creatinine, contrast volume, and Mehran score, were similar between groups.
- No significant differences were observed in other secondary outcomes like acute kidney failure, heart failure, or mortality.
Conclusions:
- Prophylactic haemofiltration (PHF) appears to be an effective strategy for preventing CIN.
- PHF may reduce the risk of kidney injury in high-risk patients undergoing PCI.
- Further prospective studies are warranted to confirm these findings.
Background:
The incidence of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) is increasing. The aim of the study is to assess the benefits of prophylactic haemofiltration (PHF) in patients with high risk of developing CIN after PCI.
Methods:
20 patients who underwent PHF after PCI in the context of acute coronary syndrome were selected retrospectively and compared with 20 matched controls with similar risk characteristics. The main variable analysed was the appearance of CIN and the secondary variables were the development of acute clinical kidney failure, heart failure, therapeutic HF and mortality.
Results:
The baseline characteristics were similar in both groups, with reference creatinine of 2.4 ± 1.3 mg/dl, contrast used 392 ± 213 cc and Mehran score of 21.9 ± 5.2 in the PHF group, as opposed to values of 2.0 ± 0.6 mg/dl, 368 ± 126 cc and 20.2 ± 6.9 respectively in controls. The incidence of CIN was of 6 patients (30%) in the PHF group and 13 patients (65%) in the control group (P=0.03). There were no significant differences in the rest of the variables studied.
Conclusion:
Haemofiltration after PCI may be an effective strategy for the prevention of CIN in patients at high risk of developing it.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Imaging Studies VII: Vascular Imaging
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
